GlassScriptPhysician profile
Kaitlin Aquino
NPI 1609491158
$5,565.61
in general payments reported to CMS, 2019-2025
20 companies · $1,561 in 2025
The $1,561 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,004 · 2022: $1,038 · 2023: $746 · 2024: $1,217 · 2025: $1,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,523.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $832.75 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $817.54 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $687.79 | 2022-2025 | |
| Novo Nordisk INC | $611.27 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $527.45 | 2023-2025 | Repatha, Otezla, Otezla |
| Janssen Pharmaceuticals, INC | $437.19 | 2021-2023 | Xarelto |
| Dexcom, INC. | $288.06 | 2022-2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $274.87 | 2021-2025 | |
| Exact Sciences Corporation | $268.96 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.27 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $160.82 | 2021-2025 | Vaxneuvance, Gardasil 9, Capvaxive |
| Xeris Pharmaceuticals, INC. | $137.23 | 2021-2025 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $128.19 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Phathom Pharmaceuticals, INC. | $92.85 | 2024-2025 | Voquezna |
| Medtronic, INC. | $30.84 | 2021-2023 | Inpen Smart Insulin Delivery System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $28.44 | 2025 | Fluad, Flucelvax |
| Kowa Pharmaceuticals America, INC. | $28.28 | 2022-2025 | Zoryve |
| Sanofi Pasteur INC. | $21.38 | 2022 | |
| Optinose US, INC. | $16.81 | 2025 | |
| Optos, INC. | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Aquino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.